医药红利 (H30095.csi)A股通融申编制方案单张 | ( 市盈率 16.68 | 市净率 1.82 | 股息率 3.32% )·市值加权 | 发布时间2013-07-02样本数50调样频率年度类型策略热点高分红收盘点位15,460.00点位涨跌幅-0.10%成交金额64.24亿元市值1.05万亿元A股市值1.01万亿元流通市值9,509.13亿元自由流通市值5,256.94亿元A股场内基金资产规模0元前十大权重29.32%发布以来年化涨跌幅6.89%有数据以来全收益年化涨跌幅9.26%陆股通持仓金额占市值比例2.05% (202.47亿元2025-09-30) 融资融券余额占市值比例2.50% (融资余额260.43亿元融券余额1.46亿元2025-12-30) | |
| 中证行业红利指数系列选取各行业股息率较高的证券作为相应行业红利指数样本，采取股息率加权计算，以反映各行业股息率较高证券的整体表现。®基础数据源自中证指数公司。指数估值数据计算说明文档指数财务数据计算说明文档 | |||||
| 备注 (3) | 双击编辑备注 | ||||
医药红利(H30095) - 历史样本权重列表
最后更新于：2025-12-08
| 2025-12-31 前十大权重: 29.32% | 2025-12-30 前十大权重: 29.31% | 2025-12-29 前十大权重: 29.25% | 2025-12-26 前十大权重: 29.30% | 2025-12-25 前十大权重: 29.21% | 2025-12-24 前十大权重: 29.20% | 2025-12-23 前十大权重: 29.24% | 2025-12-22 前十大权重: 29.27% | 2025-12-19 前十大权重: 29.28% | 2025-12-18 前十大权重: 29.31% | 2025-12-17 前十大权重: 29.36% | 2025-12-16 前十大权重: 29.40% | 2025-12-15 前十大权重: 29.47% | 2025-12-12 前十大权重: 30.20% | 2025-12-11 前十大权重: 30.49% | 2025-12-10 前十大权重: 30.37% | 2025-12-09 前十大权重: 30.43% | 2025-12-08 前十大权重: 30.42% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
华特达因.sz4.19% | 华特达因.sz4.18% | 华特达因.sz4.17% | 华特达因.sz4.20% | 华特达因.sz4.15% | 华特达因.sz4.16% | 华特达因.sz4.16% | 华特达因.sz4.16% | 华特达因.sz4.16% | 华特达因.sz4.18% | 华特达因.sz4.21% | 华特达因.sz4.19% | 华特达因.sz4.19% | 特一药业.sz3.97% | 特一药业.sz4.00% | 特一药业.sz4.14% | 特一药业.sz4.13% | 特一药业.sz4.29% |
济川药业.sh3.49% | 济川药业.sh3.52% | 济川药业.sh3.49% | 济川药业.sh3.50% | 济川药业.sh3.48% | 济川药业.sh3.47% | 济川药业.sh3.50% | 济川药业.sh3.51% | 济川药业.sh3.47% | 济川药业.sh3.51% | 济川药业.sh3.54% | 济川药业.sh3.58% | 济川药业.sh3.59% | 明德生物.sz3.45% | 明德生物.sz3.44% | 明德生物.sz3.48% | 明德生物.sz3.51% | 明德生物.sz3.52% |
葵花药业.sz3.23% | 葵花药业.sz3.23% | 葵花药业.sz3.23% | 葵花药业.sz3.21% | 葵花药业.sz3.22% | 葵花药业.sz3.22% | 葵花药业.sz3.20% | 葵花药业.sz3.24% | 葵花药业.sz3.27% | 葵花药业.sz3.27% | 葵花药业.sz3.30% | 葵花药业.sz3.33% | 葵花药业.sz3.31% | 华特达因.sz3.30% | 华特达因.sz3.29% | 华特达因.sz3.25% | 华特达因.sz3.27% | 华特达因.sz3.25% |
羚锐制药.sh2.72% | 羚锐制药.sh2.72% | 羚锐制药.sh2.69% | 羚锐制药.sh2.72% | 羚锐制药.sh2.73% | 羚锐制药.sh2.72% | 羚锐制药.sh2.73% | 羚锐制药.sh2.74% | 羚锐制药.sh2.76% | 羚锐制药.sh2.75% | 羚锐制药.sh2.74% | 羚锐制药.sh2.77% | 羚锐制药.sh2.77% | 达仁堂.sh3.20% | 达仁堂.sh3.16% | 达仁堂.sh3.14% | 达仁堂.sh3.16% | 达仁堂.sh3.13% |
西藏药业.sh2.66% | 达仁堂.sh2.66% | 达仁堂.sh2.66% | 达仁堂.sh2.70% | 达仁堂.sh2.70% | 达仁堂.sh2.65% | 达仁堂.sh2.68% | 达仁堂.sh2.67% | 达仁堂.sh2.68% | 九州通.sh2.67% | 达仁堂.sh2.67% | 九州通.sh2.64% | 达仁堂.sh2.64% | 京新药业.sz2.79% | 悦康药业.sh3.00% | 大东方.sh2.81% | 羚锐制药.sh2.80% | 羚锐制药.sh2.79% |
九州通.sh2.66% | 九州通.sh2.64% | 九州通.sh2.63% | 九州通.sh2.63% | 丽珠集团.sz2.62% | 丽珠集团.sz2.63% | 九州通.sh2.62% | 九州通.sh2.62% | 九州通.sh2.64% | 达仁堂.sh2.65% | 九州通.sh2.64% | 达仁堂.sh2.63% | 九州通.sh2.64% | 羚锐制药.sh2.78% | 京新药业.sz2.85% | 羚锐制药.sh2.79% | 京新药业.sz2.76% | 千金药业.sh2.76% |
达仁堂.sh2.63% | 西藏药业.sh2.62% | 丽珠集团.sz2.62% | 丽珠集团.sz2.62% | 九州通.sh2.61% | 九州通.sh2.62% | 圣湘生物.sh2.62% | 西藏药业.sh2.61% | 圣湘生物.sh2.61% | 圣湘生物.sh2.62% | 丽珠集团.sz2.62% | 丽珠集团.sz2.62% | 丽珠集团.sz2.62% | 悦康药业.sh2.77% | 羚锐制药.sh2.81% | 京新药业.sz2.74% | 大东方.sh2.74% | 京新药业.sz2.76% |
圣湘生物.sh2.62% | 丽珠集团.sz2.61% | 圣湘生物.sh2.62% | 圣湘生物.sh2.61% | 西藏药业.sh2.61% | 圣湘生物.sh2.61% | 西藏药业.sh2.61% | 丽珠集团.sz2.61% | 西藏药业.sh2.61% | 丽珠集团.sz2.61% | 西藏药业.sh2.57% | 圣湘生物.sh2.57% | 西藏药业.sh2.59% | 千金药业.sh2.69% | 大东方.sh2.71% | 千金药业.sh2.71% | 千金药业.sh2.74% | 悦康药业.sh2.67% |
丽珠集团.sz2.61% | 圣湘生物.sh2.61% | 西藏药业.sh2.61% | 西藏药业.sh2.60% | 圣湘生物.sh2.61% | 西藏药业.sh2.60% | 丽珠集团.sz2.60% | 圣湘生物.sh2.60% | 丽珠集团.sz2.61% | 西藏药业.sh2.54% | 圣湘生物.sh2.57% | 西藏药业.sh2.56% | 圣湘生物.sh2.59% | 大东方.sh2.66% | 千金药业.sh2.68% | 悦康药业.sh2.71% | 悦康药业.sh2.71% | 大东方.sh2.66% |
东阿阿胶.sz2.53% | 东阿阿胶.sz2.52% | 东阿阿胶.sz2.52% | 东阿阿胶.sz2.51% | 东阿阿胶.sz2.49% | 振德医疗.sh2.51% | 东阿阿胶.sz2.51% | 东阿阿胶.sz2.50% | 东阿阿胶.sz2.47% | 东阿阿胶.sz2.50% | 东阿阿胶.sz2.50% | 东阿阿胶.sz2.50% | 通化东宝.sh2.52% | 丽珠集团.sz2.59% | 可孚医疗.sz2.57% | 可孚医疗.sz2.59% | 丽珠集团.sz2.61% | 丽珠集团.sz2.60% |